KUKJEON PHARMACEUTICAL Balance Sheet Health
Financial Health criteria checks 3/6
KUKJEON PHARMACEUTICAL has a total shareholder equity of ₩99.9B and total debt of ₩73.6B, which brings its debt-to-equity ratio to 73.7%. Its total assets and total liabilities are ₩220.7B and ₩120.8B respectively. KUKJEON PHARMACEUTICAL's EBIT is ₩3.2B making its interest coverage ratio 0.5. It has cash and short-term investments of ₩52.4B.
Key information
73.7%
Debt to equity ratio
₩73.61b
Debt
| Interest coverage ratio | 0.5x |
| Cash | ₩52.41b |
| Equity | ₩99.86b |
| Total liabilities | ₩120.84b |
| Total assets | ₩220.70b |
Financial Position Analysis
Short Term Liabilities: A307750's short term assets (₩113.6B) exceed its short term liabilities (₩94.7B).
Long Term Liabilities: A307750's short term assets (₩113.6B) exceed its long term liabilities (₩26.1B).
Debt to Equity History and Analysis
Debt Level: A307750's net debt to equity ratio (21.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if A307750's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A307750's debt is not well covered by operating cash flow (11.4%).
Interest Coverage: A307750's interest payments on its debt are not well covered by EBIT (0.5x coverage).